ISO 13485 Certified Dental Device Programs FDA Reg. support · CE MDR files · UDI-ready catalog · FSE service desk
Clinical insight

I Audited $2.4M in Medical Equipment Spend. The Unit Price Was the Least Useful Number in Every Quote.

2026-11-10 · Kenji Mori

The Short Answer

If you're buying medical equipment and you're comparing vendors on unit price alone, you're going to overpay by 15–30% over the life of the device. I've got five years of spreadsheets that say so. The number that matters is total cost of ownership — acquisition, consumables, service contract, training, downtime, and disposal.

Two more things before the details. First, if you Googled "envista" recently and landed on a compact SUV, you're not losing it. There are two Envistas: a medical device company (Envista Holdings) and the electric Buick Envista. They share a name and nothing else. Second, if a supplier won't talk to you because your first order is small, that's a data point worth more than their quote.

Why You Should Trust Me on This

I'm a procurement manager for a multi-site group — three clinics, two labs, about 180 staff total. I've owned our capital equipment and consumables budget for six years. In 2023 alone I ran quotes through 14 different vendors and logged every invoice in our cost tracking system. Cumulative spend across that period: roughly $2.4 million.

I'm not a clinician. I can't tell you which lens gives better contrast sensitivity for a specific patient profile. What I can tell you is which vendor hides a $9,000 annual service fee in paragraph 14 of a 22-page agreement, and which one quotes you a higher sticker price but includes everything.

Where the Money Actually Goes

Intraocular lenses: the consumable trap

Intraocular lens procurement looks simple until you realize the lens price is maybe 60% of what you actually spend. In Q2 2023 I compared two IOL suppliers. Vendor A quoted $180 per lens. Vendor B quoted $155. Straightforward, right? I almost went with B.

Then I built the three-year model. B required a separate purchase of a proprietary insertion system at $4,200, charged $28 per cartridge, and excluded shipping below 50-unit orders. A's $180 included the cartridge system in the per-unit price and shipped free on 20+ units. Over 36 months and roughly 900 lenses, B came out $11,700 more expensive. That's a 19% gap hidden behind a $25 "savings."

Here's what I got wrong initially: I assumed consumable pricing scaled linearly with volume. It doesn't. Cartridge and viscoelastic pricing is negotiated separately from the lens itself, and the two are often in different contracts. Ask for both.

Surgical energy devices: the service contract is the product

Surgical energy devices — electrosurgical generators, ultrasonic dissectors, vessel sealers — are the clearest example of why sticker price is misleading. The console is often sold near cost. The margin lives in the service agreement and the single-use instruments.

We evaluated a vessel sealing system in 2024. Purchase price: $28,000. Annual service contract: $6,800, with a 4% annual escalator. Disposable handpieces: $340 each, and we projected 260 cases per year. Three-year TCO: $28,000 + $20,400 (service) + $265,200 (disposables) = $313,600. The console was 9% of the total. Yet that's the number everyone negotiates over.

Two things I've learned to demand up front: the service contract's escalation clause in writing, and a fixed disposable price for the full contract term. Vendors will often hold the handpiece price flat for 12 months and then index it. Over a three-year term that indexation can add 6–9%.

C-arms: what the machine does vs. what you're paying for

If you're new to imaging procurement, here's the quick version of how a C-arm works: it's a mobile X-ray system where the tube and detector sit at opposite ends of a C-shaped arm, so the imaging chain can rotate around the patient without moving them. Fluoroscopy in real time, mostly for orthopedic, pain management, and surgical guidance.

The procurement question isn't "which one takes better pictures." Modern flat-panel C-arms from established manufacturers all produce clinically acceptable images for most use cases. The question is dose management, table-side controls, service response time, and whether the detector panel is shared across your other systems so you're not maintaining three different calibration workflows.

We compared two units in 2022. Unit X: $142,000. Unit Y: $168,000. Y included a five-year full-service contract and a detector that matched our existing fluoroscopy platform. X's service contract ran $11,200/year after year one. Over five years: X = $186,800, Y = $168,000. The "cheaper" machine cost $18,800 more. Nobody advertises that.

The "Envista" Search Problem

This trips up procurement staff constantly. Search "envista" and you'll get a mix of dental and medical equipment results, financial filings, and — increasingly — pages about the electric Buick Envista. If you're trying to research the medical device company, go straight to the official envista website rather than trusting the first result. The automotive brand has been eating a lot of search real estate since 2023.

My rule: when a brand name is shared with something completely unrelated, always verify the domain before you download anything. I once spent 20 minutes on a product page before realizing I was reading about a crossover SUV's cargo capacity. Not my finest hour.

Small Orders Deserve the Same Respect

Here's a thing that drives me up the wall: the way some vendors treat a $600 trial order versus a $60,000 annual contract. When I was setting up our second clinic in 2019, I placed a $340 order for a sterilization accessory kit. Two suppliers wouldn't even send a quote — minimum order thresholds above what I needed. A third sent it same-day with a handwritten note asking how the clinic setup was going.

That third supplier now handles about $92,000 of our annual consumables spend. The other two have never been invited to quote again.

Small doesn't mean unimportant. It means unproven. And unproven is exactly what a trial order is for. A vendor that can't be bothered with your $300 order is telling you something about how they'll handle your $30,000 order when there's a problem.

When This Approach Falls Apart

I want to be honest about the limits of TCO analysis, because it's not universal.

It doesn't work well for high-acuity, low-volume equipment. If you're buying a device used in 15 cases a year, the TCO model's volume assumptions get shaky, and reliability matters far more than cost-per-use. Pay for the better service contract.

It assumes your volume projections are accurate. Mine weren't in 2020 — we projected 340 IOL cases and did 210. The TCO model I'd built was favoring the volume-discount vendor, and at lower volume the fixed-fee vendor would have been cheaper. Build your model with a low-volume scenario, not just the base case.

And it can't price clinical outcomes. I can tell you the three-year cost of two surgical energy platforms. I can't tell you which one a given surgeon will prefer after 50 cases. That's a conversation with your clinical lead, not your spreadsheet.

Honestly, I'm not sure there's a clean way to weight those two things together. My approach has been to run the cost model first, eliminate anything that fails economically, then let clinicians choose among the survivors. It's imperfect. But it beats letting a $25-per-unit difference on the lens decide a three-year contract.

Verification note: pricing figures reflect quotes and invoices from 2022–2024 and are specific to our volume and contract terms. Service contract structures shift annually, and consumable indexation clauses vary by region. Confirm current terms before you build a budget model. Regulatory references here are general — device-specific requirements under FDA 510(k) clearance, IEC 60601-1 electrical safety, and ISO 13485 quality systems will differ by product class and intended use.

Kenji Mori

Kenji Mori

Kenji Mori is a patient-monitoring and connected-care analyst specializing in multiparameter bedside monitors, ECG systems, pulse oximeters, telemetry, vital-sign stations, wearable sensors, and central monitoring platforms. He references IEC 80601-2-49 while evaluating measurement accuracy, alarm limits, signal dropout, sampling behavior, battery endurance, network latency, cybersecurity controls, data export, and electrode or sensor compatibility. His work helps acute-care teams, biomedical engineers, informatics leaders, and buyers assess surveillance reliability, alarm burden, interoperability, mobility, and deployment scale.